Studies done five years ago when Pfizer's Celebrex and Merck &amp; Co.'s Vioxx were approved suggest the same mechanism that inhibits inflammation and makes them easier on the stomach than traditional painkillers also blocks a substance that prevents heart problems, according to Dr. Garret FitzGerald, chairman of pharmacology at the University of Pennsylvan
The controversy grew Friday when Grassley asked Merck, among other things, about an e-mail provided by Graham in which a Merck official complained that the FDA had not lived up to a prior agreement to alert the company before releasing any negative information about its products.
